Beneficient (BENF) Form 8-K — Nov 16, 2026
Beneficient reported a fiscal Q2 2027 loss with GAAP revenues of negative $25.3 million and a net loss of $39.4 million, including a $1.5 million goodwill impairment and heavy intersegment credit losses. Net loss attributable to common shareholders was $22.1 million, or $(1.49) per share. Positives in the quarter were cost discipline (adjusted operating expenses down 20.1% YoY to $10.7 million), a $7.4 million GP Primary Capital transaction with an AI/tech-focused investment firm, a second collateral management transaction, and plans to launch the AltLens analytics platform.
Key figures
- Total Debt
- 98100000
- Total Assets
- 227281000
- Cash Position
- 7476000
- Shares Outstanding
- 18,957,000 Class A shares outstanding as of September 30, 2026 (post 1-for-8 reverse split of December 15, 2025)
- Custody nav
- $220.9 million
- Prior year ytd eps
- -$58.68
- Goodwill impairment
- $1.5 million
- Operating expenses q2
- $14.1 million (down 6.9% YoY)
- Gaap operating loss q2
- $39.3 million
- Investments fair value
- $201.0 million
- Purported heppner debt
- $130 million
- Adjusted operating loss q2
- $23.5 million
- Allowance for credit losses
- $436 million against $608 million gross loan balance
- Adjusted operating expenses q2
- $10.7 million (down 20.1% YoY)
- Asset sale proceeds cumulative
- $60.5 million
- Ben liquidity net loan portfolio
- $172.3 million
- Net loss attributable common shareholders q2
- $22.1 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.